Various research groups have elucidated the effects of MACC1 on mechanisms of resistance towards chemotherapeutic drugs across a wide range of tumor types, including glioblastoma, colorectal, gastric, and pancreatic cancers [41, 115, 173, 175]. Here, MACC1 is linked to familial pancreatic carcinoma.